Boardroom Alpha
Boardroom Alpha
NAII · Current Report (Form 8-K) · Filed December 12, 2025

Natural Alternatives International Inc — Current Report (Form 8-K)

Form
8-K
Filed
December 12, 2025
Period
Dec 5, 2025
Ticker
NAII
Accession
0001437749-25-037601
Boardroom Alpha · Filing insights

Alan G Dunn elected; equity plan amendment, Haskell & White LLP, executive pay, and 3-year say-on-pay approved.

About Natural Alternatives International Inc
Market cap
$16M
1Y TSR
−22.4%
3Y TSR
−29.5%
Board grade
B-
Sector
Consumer Defensive
CEO
Mark A Ledoux
naii20251212_8k.htm
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 8-K
 

 
CURRENT REPORT
 
pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
DATE OF REPORT (Date of earliest event reported): December 5, 2025
 
000-15701
(Commission file number)
 

 
NATURAL ALTERNATIVES INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
 

 
Delaware
84-1007839
(State of incorporation)
(IRS Employer Identification No.)
   
1535 Faraday Avenue
Carlsbad, California 92008
(760) 736-7700
(Address of principal executive offices)
(Registrants telephone number)
 

 
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common
NAII
NASDAQ
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 

 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
 
ITEM 5.07
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
 
Our Annual Meeting of Stockholders was held on December 5, 2025. The following table sets forth the matters voted upon at the meeting and the results of the voting on each matter voted upon:
 
Matter Voted Upon
 
Votes For
   
Withheld
   
Votes
Against
   
Abstentions
   
Broker
Non-Votes
 
Election of one Class II director to serve until the next annual meeting of stockholders held to elect Class II directors and until such director’s successor is elected and qualified:
                                       
                                         
Alan G Dunn
    3,096,094       132,700                   1,519,356  
                                         
Approval of the First Amendment to the 2020 Omnibus Equity Incentive Plan
    3,025,686             195,970       7,138       1,519,356  
                                         
Ratification of the selection of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026
    4,660,314             83,683       4,153        
                                         
To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers
    3,092,272             99,248       37,274       1,519,356  
                                         
An advisory, non-binding vote regarding the frequency of voting by the stockholders on the executive compensation of the Company's executive officers
                                       
One year
    1,165,476                          
Two years
    20,602                          
Three years
    2,006,157                          
Abstentions and non-votes                       36,199       1,519,356  
 
The election of the one named director, the First Amendment to the 2020 Omnibus Equity Incentive Plan, the Ratification of Haskell & White, the compensation of the named executive officers, and the three-year frequency of non-binding votes on executive compensation were each approved by the stockholders at the annual meeting.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
Natural Alternatives International, Inc.
     
     
     
Date: December 11, 2025
By:
/s/ Michael E. Fortin
   
Michael E. Fortin
   
Chief Financial Officer
 
 
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Natural Alternatives International Inc (NAII)

Reference

Frequently asked questions

When did Natural Alternatives International Inc file this 8-K?
Natural Alternatives International Inc (NAII) filed this Current Report (Form 8-K) with the SEC on December 12, 2025. The accession number assigned by EDGAR is 0001437749-25-037601.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Alan G Dunn elected; equity plan amendment, Haskell & White LLP, executive pay, and 3-year say-on-pay approved. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Natural Alternatives International Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Natural Alternatives International Inc has filed under CIK 787253, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer